Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

MEDPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.8%1-day move

₹866.65

prior close

₹870.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.6+0.6+0.5+2.8+5.6+4.4+4.0+0.6+1.3+3.2+9.7-3.7-8.7

Up moveDown movePending

AI summary

Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received two drug license suspension orders from drug control authorities. The first suspension is for 7 days for a store at Kodumur New Bus Stand in Andhra Pradesh, received on April 19, 2026, citing violations under the Drugs and Cosmetics Act, 1940. The second suspension is for 2 days for a store at Miryalaguda Road, Bottu Guda in Telangana. Both suspensions result in a combined potential revenue loss of Rs 1.25 lakhs (Rs 0.88 lakhs + Rs 0.37 lakhs). The company has disclosed this as a material event under SEBI regulations.

Likely market impact

The impact on the company is minimal given only 2 stores are affected with short-term suspensions and a combined revenue exposure of just Rs 1.25 lakhs. This is unlikely to materially affect the stock price or investor sentiment.